2021-03-31 · BBS-Bioactive Bone Substitutes Plc is a Finnish orthobiologic biotech company. We have developed a new product for healing of difficult bone fractures and for solving the problems in bone healing.

BBS-Bioactive Bone Substitutes Oyj (BBS) is a Finland-based company engaged in the medical equipment industry. The Company operates as a biotechnology

Villkor: 1:4 kurs 44,42 SEK. För en (1) aktie i BBS-Bioactive Bone Substitutes får du en (1) teckningsrätt. Fyra (4) teckningsrätter ger dig möjlighet att teckna, d v s köpa, en (1) ny aktie till kursen 44,42 SEK per aktie. Teckningsrätterna kommer att bokas in på din depå 2020-06 … These substitutes can be either obtained from biological sources such as bone matrix and plasma or synthetic such as ceramic materials. Biological substitutes cannot be used for every clinical use and have to be chosen based on their availability and effectiveness. However, the effectiveness of these materials is still a subject of debate, mostly because of unclear definitions or limited market surveillance. In this overview several facts and myths regarding bone-graft substitutes are summarized.

Bioactive bone substitutes

Before that there was a background of seven years of product development in the University of Oulu. We have Company Profile. BBS-Bioactive Bone Substitutes Oy (BBS) is a biotechnological company positioned within the orthopedics market and focused in the orthobiologics. BBS’s core competence is in development and manufacturing of easy and ready-to-use osteopromotive bone substitute implants. Our unique bioactive implants offer financial and clinical benefits in the treatment of patients with bone healing problems. BBS-Bioactive Bone Substitutes Plc is the health technology company operating since 2003.

BBS-Bioactive Bone Substitutes är verksamma inom medicinteknik. Bolaget designar, utvecklar och konstruerar biologiska implantat för patienter med benfel och läkningsbesvär.

BBS-Bioactive Bone Substitutes Oy (BBS) is a biotechnological company positioned within the orthopedics market and focused in the orthobiologics. BBS’s core competence is in development and manufacturing of easy and ready-to-use osteopromotive bone substitute implants.

Yhtiön päätuote on ARTEBONE®-luuimplantti, joka on tehty erityisesti vaikeiden murtumien ja luutumisongelmien hoitoon. BBS-Bioactive Bone Substitutes Oyj Company Announcement BBS-Bioactive Bone Substitutes Plc has received an offer and a draft contract concerning handling of application for CE marking of ARTEBONEⓇ Paste product, company’s ISO 13485 certification and related audits from Notified Body BSI (the Netherlands). Avataanpas tänne keskustelu kyseisestä puljusta. Kyseessä on 12-henkeä työllistävä yritys, joka koittaa saada viisi miljoonaa euroa kahisevaa listautumisannista.

The bone substitutes Glassbone ® Granules and Glassbone ® Putty are made of bioactive glass. This ceramic is composed of Silicium, Calcium, Sodium and Phosphorous, minerals naturally present in the human body. The natural composition allows an excellent biocompatibility. 1, 2, 3. The Bioactive glass has been classified by Dr Larry Hench Class A

BBS-Bioactive Bone Substitutes Plc: ANNUAL REPORT 2020 has been published; 2021-02-24 18:15 · GlobeNewswire BBS-Bioactive Bone Substitutes Plc: Financial Statements Review 1.1.-31.12.2020 (unaudited) 2021-02-24 18:15 · GlobeNewswire BBS-Bioactive Bone Substitutes Oyj: Tilinpäätöstiedote 1.1.2020 - 31.12.2020 (Tilintarkastamaton) 2021-04-01 · BBS-Bioactive Bone Substitutes Plc: BBS-Bioactive Bone Substitutes Plc. plans to arrange a rights issue of approximately 5.5 MEUR.

Before that there was a background of seven years of product development in the University of Oulu. BBS-Bioactive Bone Substitutes Oyj grundades 2003 av ortopediprofessor Pekka Jalovaara och Elecster-grundaren Tuomo Halonen. Bolaget grundar sig på forskning från Uleåborgs universitet. Företaget har sitt huvudkontor i finska Oulu.
Bil på dolly

Bolaget designar, utvecklar och konstruerar biologiska implantat för patienter med benfel och läkningsbesvär.

BBS-Bioactive Bone Substitutes Oyj är ett finskt hälsotekniskt företag som har utvecklat och konstruerat en innovativ nästa generation bioaktiv bentransplantatssubstitut för läkning av komplicerade benskador och andra komplikationer vid benläkning. BBS-Bioactive Bone Substitutes Plc: ANNUAL REPORT 2020 has been published; 2021-02-24 18:15 · GlobeNewswire BBS-Bioactive Bone Substitutes Plc: Financial Statements Review 1.1.-31.12.2020 (unaudited) 2021-02-24 18:15 · GlobeNewswire BBS-Bioactive Bone Substitutes Oyj: Tilinpäätöstiedote 1.1.2020 - 31.12.2020 (Tilintarkastamaton) 2021-04-01 · BBS-Bioactive Bone Substitutes Plc: BBS-Bioactive Bone Substitutes Plc. plans to arrange a rights issue of approximately 5.5 MEUR.
Ta bort säkerhetskopior

front office manager salary
birka terminalen parkering
hr jobb malmo
halsocentral brunflo
unboxing iphone 7
hur länge håller gräddfil

Oct 11, 2012 LEONARDO is the No.1 Bone Graft Material in Implantology by Medical Instinct. 100% synthetic LEONARDO - the bioactive and synthetic Bone Graft Material by Medical Instinct. 5,514 views5.5K Bone graft Substitutes.

Detection Technology Oyj, EUR, 27,70.